What is the appropriate dosing regimen of propranolol for managing antidepressant‑induced tremor?

Propranolol Dosing for Antidepressant-Induced Tremor

For antidepressant-induced tremor, start propranolol at 30-40 mg daily in divided doses and titrate to 120-240 mg daily based on response, as optimal tremor suppression typically occurs at these moderate doses without requiring higher amounts.

Evidence-Based Dosing Strategy

Starting Dose

• Begin with 30-40 mg daily in 2-3 divided doses 1, 2
• This low starting dose often provides significant tremor reduction, sometimes with unmeasurable plasma propranolol levels 2
• Single-dose administration of 40 mg has demonstrated tremor-reducing effects in controlled studies 3

Titration Protocol

• Increase by 30-40 mg increments weekly if tremor persists 4
• Most patients achieve maximum benefit at 120-240 mg daily in divided doses 1, 5, 6
• The optimal dose range for tremor suppression is typically 160-320 mg daily, with maximum suppression occurring within this window 4

Maintenance Dosing

• Target dose: 120-240 mg daily divided into 2-3 doses 1, 6
• At 120 mg daily, propranolol demonstrates superiority over placebo based on performance tests and patient self-assessment 6
• At 240 mg daily, propranolol shows superiority over placebo across all assessment methods 6
• Higher doses beyond 320 mg do not provide additional tremor reduction and increase side effect risk 4

Key Clinical Considerations

Dose-Response Relationship

• Tremor control varies greatly between individuals - some achieve complete suppression at 80 mg daily while others show no reduction even at 800 mg daily 4
• Plasma propranolol levels do not correlate with tremor suppression, making therapeutic drug monitoring unhelpful 1, 2
• Clinical evaluation of tremor is the best guide for dosing, not serum drug levels 2

Factors Predicting Response

• Patients with larger baseline tremor amplitude respond better to propranolol (correlation rs = 0.71, p < 0.01) 5
• Those with hand tremor greater than 6 × 10⁻³ cm displacement achieve 65% tremor reduction versus only 17% in those below this threshold 5
• Tremor with lower peak frequency shows better response (rs = -0.53, p < 0.05) 5

Mechanism and Context

• Propranolol reduces tremor through cortical mechanisms, specifically decreasing tremor-related activity in the primary motor cortex 3
• The tremor-reducing effect is context-independent and not limited to stressful situations 3
• This distinguishes it from stress-related tremor exacerbation seen with antidepressants 7

Important Caveats

Tolerability Limits

• Some patients cannot tolerate doses above 640 mg daily due to side effects 4
• Common limiting factors include bradycardia, hypotension, fatigue, and sleep disturbances
• If side effects occur, maintain the highest tolerated dose rather than discontinuing entirely

Drug-Specific Considerations

• Antidepressants most commonly causing tremor include SSRIs/SNRIs, amitriptyline, and lithium 7
• Consider whether the tremor might resolve with antidepressant dose reduction or switching agents before committing to long-term propranolol 7
• Avoid β-blockers with partial agonist activity (pindolol, labetalol) as these can paradoxically worsen tremor 8

Monitoring Strategy

• Assess tremor clinically 7-14 days after each dose adjustment 2
• Evaluate 12-15 hours after the last dose to assess trough effect 2
• Do not rely on plasma propranolol concentrations for dose titration 1, 2

Alternative if Propranolol Fails

• If inadequate response at 240-320 mg daily, consider primidone as an alternative first-line agent (Level A evidence for essential tremor) 9
• Gabapentin monotherapy, topiramate, or alprazolam are second-line options (Level B evidence) 9